Expand MRNA Menu
MRNA MENU

Moderna (MRNA) closed at $196.79 on November 18, 2026, down 4.8% from the previous close, on volume of 6,457,485 shares (30-day average 15,082,652).

Key numbers
  • Last close: $196.79 (November 18, 2026)
  • 52-week range: $22.28 to $280.80
  • Market value: $78.0 billion
  • 30-day implied volatility (IV30): 80.6%
  • Option volume: 65,488 contracts (37,226 calls, 28,262 puts); 30-day average 144,077

Data as of November 18, 2026.

MRNA Stock Summary and Trading Ideas (Moderna | NASDAQ:MRNA)

Charts for Today's Stock Price and Implied Volatility in Moderna

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for MRNA by Theoretical Edge and Win Rates

Sentiment

Largest Multi-Leg Option Trades (30 Days)

#DateStrategyLegsContractsPosition
1 Oct 30, 2026 Diagonal Double Call Spread 30-Oct-26210 : 222.5 C|06-Nov-26232.5 : 247.5 C 19,700
2-3 The next 2 largest trades are for Premium members. Start a 7-day free trial

Premium Feature

Login|Subscribe

Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 17, 2026. See the largest for 5, 30, 60 and 90 days

Trading Statistics

Key Ratios

Moderna (MRNA) Frequently Asked Questions

What does Moderna do?

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

What symbol and exchange does Moderna shares trade?

Moderna trades on the NASDAQ stock market under the symbol MRNA.

What is Moderna stock price doing today?

As of November 18, 2026, MRNA stock price declined to $196.79 with 6,457,485 million shares trading.

What is Moderna's Beta?

MRNA has a beta of 0.11, meaning it tends to be less sensitive to market movements. MRNA has a correlation of 0.00 to the broad based SPY ETF.

How much is Moderna worth?

MRNA has a market cap of $78.04 billion. This is considered a Large Cap stock.

How much money does Moderna make?

Last quarter Moderna reported $1 billion in Revenue and $.38 earnings per share. This beat revenue expectation by $423 million and exceeded earnings estimates by $1.60.

What is the highest and lowest price Moderna traded in the last 3 year period?

In the last 3 years, MRNA traded as high as $280.80 and as low as $22.28.

What are the top ETFs holding Moderna?

The top ETF exchange traded funds that MRNA belongs to (by Net Assets): VTI, VOO, QQQ, IVV, SPY.

Is Moderna (MRNA) a good investment?

MRNA has outperformed the market in the last year with a return of +694.8%, while the SPY ETF gained +10.8%. In the last 3 month period, MRNA beat the market returning +205.3%, while SPY returned -5.3%. However, in the most recent 2 weeks MRNA has underperformed the stock market by returning -13.9%, while SPY returned -3.2%.

What are the support and resistance levels for Moderna (MRNA)?

MRNA support price is $194.16 and resistance is $219.44 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MRNA shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes